Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Avenue Therapeutics, Inc. ATXI
$1.04
+$0.02 (1.96%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
6122475.00000000
-
week52high
16.65
-
week52low
0.87
-
Revenue
0
-
P/E TTM
-1
-
Beta
-0.43148700
-
EPS
-1.69000000
-
Last Dividend
0.00000000
-
Next Earnings Date
30 мар 2023 г. в 20:01
Описание компании
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 12 мая 2020 г. |
| Oppenheimer | Outperform | 13 июл 2018 г. | |
| H.C. Wainwright | Buy | 25 июн 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fortress Biotech, Inc. | A | 561561 | 231316 | 03 янв 2023 г. |
| Fortress Biotech, Inc. | A | 330245 | 90909 | 31 дек 2022 г. |
| InvaGen Pharmaceuticals, Inc. | D | 0 | 388888 | 11 окт 2022 г. |
| Herskowitz Neil | A | 183744 | 20000 | 17 дек 2021 г. |
| Herskowitz Neil | A | 163744 | 49020 | 17 дек 2021 г. |
| Oltmans Curtis Gale | A | 49020 | 49020 | 17 дек 2021 г. |
| KRANZLER JAY D | A | 133683 | 20000 | 17 дек 2021 г. |
| KRANZLER JAY D | A | 113683 | 49020 | 17 дек 2021 г. |
| Vazzano Joseph Walter | A | 165757 | 100505 | 17 дек 2021 г. |
| Lu Lucy | A | 748949 | 411616 | 17 дек 2021 г. |
Новостная лента
Avenue Therapeutics to Present at Aegis Capital Virtual Conference
GlobeNewsWire
27 апр 2023 г. в 08:30
MIAMI, April 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the Aegis Capital Virtual Conference taking place on Thursday, May 4, 2023, at 4:00 p.m. EDT.
These Were The Five Best And Worst Performing Healthcare Stocks In September 2022
24/7 Wall Street
17 окт 2022 г. в 19:41
September was another lackluster month for the stock market, with the S&P 500 dropping by over 9%.
New to Trading Penny Stocks? Must Knows in 2022
PennyStocks
16 окт 2022 г. в 11:30
Are these methods part of your penny stocks trading strategy The post New to Trading Penny Stocks? Must Knows in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
What In The World Is Going On With Avenue Therapeutics Stock?
Benzinga
07 окт 2022 г. в 09:21
Avenue Therapeutics Inc (NASDAQ: ATXI) shares are trading lower by 62.64% to $2.35 Friday morning after the company priced a roughly 3.6 million unit offering at $3.30 per unit.
ATXI Stock Alert: What to Know as Avenue Therapeutics Soars 150%
InvestorPlace
27 сент 2022 г. в 13:40
It's been another bumpy day in the stock market, with many stocks opening higher only to lose momentum this afternoon. That said, some companies are outperforming meaningfully today.